Pawan Kumar Bansal: Gustakhi Maaf Haryana
Who is the manufacturer of this ? This is a ploy to get out of DPCO.
MRP 5400.00
As per DPCO / GO
MRP should not be more than 1067.00
How Pharma companies are mining money/cheating poor ailing patients circumventing Legal provisions?Our Investigatiions . Part one.Investigations based on talk with cross section of stakeholders has revealed startling disclosure and it has all the ingredients of a potbelly Mumbai thriller having manipulation of Legal provisions, lust for money and tacit patronage of regulating authority all at the cost of poor and innocent patients.– Drug formulation units engaged in mfg of forth generation antibiotics are stated to be procuring Meropenem ( bulk sterile API) at around 45000/- per kg (Rs 45/- per gm) as per some Indian leading Sterile API manufacturer.
In case of Meropenam with Edetate or Sodium carbonate (as stabilisers) cost is around 46000/-
This product with MRP of 5000 or more is being sold to the ailing mankind indicate the ……..of this noble profession. There is immediate need to curb such malpractice by the NPPA as well the CDSCO/ SLAs in larger public interest.
— How pharm companies are minting money/ cheating ailing patients by circumventing legal provisions of the statues is evident from this life- saving drug product ( a forth generation antibiotic) mostly given post surgery.
This formulation contains “Meropenem” which is active pharm ingredient required by the body as it is therapeutical active. While Disodium EDTA is inactive and not required to by the body as it is without therapeutic efficacy.
It appears to have been added in the product to circumvent clutches of DPCO 2013- a central price control order/law under Essential Commodity Act 1956.
The manufacturer has labeled its MRP as 5400/- while as per DPCO 2013, it should have been around 1000/-.
This is a ploy to get out of DPCO.
This amounts to cheating to the ailing mankind.
As per the label it appears to be a product manufactured at WHO-GMP Certified Pharma Unit ??. CDSCO and State Regulators to look in to and save the poor patients from clutches of such unscrupulous manufacturer / marketers. There is need to curb such malpractice by the Drug regulators entrusted with duties under Drugs Act. Purpose of such FDC is evident and only to circumvent DPCO.
CDSCO and SLA to take a urgent call. There is flaw in basic DPCO 2013.It is need of hour that if any drug comes under the ambit of DPCO 2013 it should notified with active ingredient and if all its combination without naming it.So that no company should take advantage by changing by one or more ingredient (active or recipients) in the formulations.Other products of the same ingredients have different prices.Expressing shock at open loot and cheating of poor patients,SK,Singla retired Drugs Controller, Haryana told”Gustakhi Maaf Haryana”that Drug regulators need to look into such illegal, inhuman malpractice and protect the ailing mankind from clutches of such unscrupulous elements.
Tailpiece.Sometimes back addressing a gathering at Gurugram Union Health Minister has boasted that India is producing cheapest medicines in the This scribe who was present in the gathering had asked as what the government is doing to check the”drugs mafia”who is looting people in name of MRP, instead of replying he accused me of asking planted question.To be continued.Bansal , author of book”Tips for Investigative Journalism”can be contacted at pawanbansal२@gmail.com.January 1२ ,२०२४, Gurugram.
